Evidence map›Paper›PMID 12527748›Full record

ArticleThe Journal of cell biology2003

Tenascin-C signaling through induction of 14-3-3 tau.

Doris Martin, Marianne Brown-Luedi, Ruth Chiquet-Ehrismann

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. 14-3-3τ drives estrogen receptor loss via ERα36 induction and GATA3 inhibition in breast cancer.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  3. Review
  4. Radioimmunotherapy (RIT) in Brain Tumors.Nuclear medicine and molecular imaging · 2019
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. How do tenascins influence the birth and life of a malignant cell?Journal of cellular and molecular medicine · 2012
    Review
  12. Tenascins and the importance of adhesion modulation.Cold Spring Harbor perspectives in biology · 2011
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The role of tenascin-C in tissue injury and tumorigenesis.Journal of cell communication and signaling · 2009
    Article
  19. Article
  20. Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Doris MartinFriedrich Miescher Institute, Novartis Forschungsstiftung, CH-4002 Basel, Switzerland.
Marianne Brown-Luedi
Ruth Chiquet-Ehrismann
Novartis (Switzerland) · CHFriedrich Miescher Institute · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We searched by a cDNA subtraction screen for differentially expressed transcripts in MCF-7 mammary carcinoma cells grown on tenascin-C versus fibronectin. On tenascin-C, cells had irregular shapes with many processes, whereas on fibronectin they were flat with a cobble stone-like appearance. We found elevated levels of 14-3-3 tau transcripts and protein in cells grown on tenascin-C. To investigate the consequences of an increased level of this phospho-serine/threonine-binding adaptor protein, we transfected MCF-7 cells with a construct encoding full-length 14-3-3 tau protein and selected clones with the highest expression levels. The morphology of these cells on tenascin-C was flat, resembling that of cells on fibronectin. This was reflected by a similar pattern of F-actin staining on either substratum. Furthermore, the growth rate on tenascin-C was increased compared with the parental cells. After transient transfection of HT1080 fibrosarcoma and T98G glioblastoma cells with 14-3-3 tau, only the 14-3-3 tau-expressing cells were able to adhere and survive on tenascin-C, whereas all cells adhered well on fibronectin. Therefore, we postulate that tenascin-C promotes the growth of tumor cells by causing an increase in the expression of 14-3-3 tau, which in turn has a positive effect on tumor cell adhesion and growth.

Indexed as

14-3-3 ProteinsApoptosisBreast NeoplasmsCarcinomaCell AdhesionCell DivisionCell SurvivalFemaleFibronectinsGene Expression Regulation, NeoplasticGlyceraldehyde-3-Phosphate DehydrogenasesHumansNeoplasm MetastasisSignal TransductionTenascinTumor Cells, Cultured14-3-3 ProteinsFibronectinsGlyceraldehyde-3-Phosphate DehydrogenasesTenascinTyrosine 3-Monooxygenase

Identifiers

PMID12527748
PMCPMC2172641
OpenAlexW2018929938

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.